$449 Million

10x Genomics, Inc.

Initial Public Offering

Lead Manager, September 2019

10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company building products to interrogate, understand and master biology. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale to match the complexity of biology. 10x has built deep expertise across diverse disciplines including chemistry, biology, hardware engineering and software. Innovations in all of these areas have enabled the Company’s rapidly expanding suite of products, which allow the Company’s customers to interrogate biological systems at previously inaccessible resolution and scale. 10x’s Chromium and recently announced Visium product lines provide this resolution and scale along distinct but complementary dimensions of biology.